摘要
大样本双盲的随机对照试验(RCT)结果历来代表循证医学临床证据的最高等级,但它无法解决所有的临床研究问题,因此基于真实世界研究(RWS)视角下的真实世界证据(RWE)得到了迅速发展。本文通过对比生成真实世界证据与随机对照试验证据在数据来源、内外部有效性、证据等级、应用范围、试验设计、实施要素、实施成本中的差异,旨在为真实世界证据的进一步应用发展提供参考。
Results from large-sample double-blind randomized controlled trial(RCT)have always represented the highest level of evidence-based medicine clinical evidence,but it cannot solve all the clinical research problems,thus real-world evidence(RWE)based on the perspective of real-world research(RWS)has developed rapidly.This paper aims to provide reference for the further application and development of RWE by comparing the differences between RWE and randomized controlled trial evidence in data source,internal and external effectiveness,evidence level,application scope,experiment design,implementation elements and implementation cost.
作者
张喻
曲艺
董丽
孟令全
黄哲
陈玉文
ZHANG Yu;QU Yi;DONG Li;MENG Ling-quan;HUANG Zhe;CHEN Yu-wen(Shenyang Pharmaceutical University School of Business Administration,Shenyang 110016,China;Shenyang Pharmaceutical University Shenyang Pharmaceutical University/Institute of Pharmaceutical Regulatory Sciences,Shenyang 110016,China)
出处
《中国新药杂志》
CAS
CSCD
北大核心
2021年第11期971-975,共5页
Chinese Journal of New Drugs
基金
国家药品监督管理局药品监管科学研究基地-沈阳药科大学药品监管科学研究院专项基金资助项目(2020jgkx005)。